5:57 PM
 | 
Oct 10, 2012
 |  BC Extra  |  Company News

STC receives $2.5M government contract for biosimilar mAb

Biosimilars company STC Biologics Inc. (Cambridge, Mass.) received a $2.5 million Small Business Innovation Research contract from the National Cancer Institute (NCI) to develop...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >